In last trading session, Cabaletta Bio Inc (NASDAQ:CABA) saw 1.56 million shares changing hands with its beta currently measuring 2.43. Company’s recent per share price level of $17.54 trading at -$0.58 or -3.20% at ring of the bell on the day assigns it a market valuation of $751.59M. That closing price of CABA’s stock is at a discount of -50.23% from its 52-week high price of $26.35 and is indicating a premium of 60.43% from its 52-week low price of $6.94. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.31 million shares which gives us an average trading volume of 880.45K if we extend that period to 3-months.
Cabaletta Bio Inc (NASDAQ:CABA) trade information
Upright in the red during last session for losing -3.20%, in the last five days CABA remained trading in the red while hitting it’s week-highest on Friday, 03/15/24 when the stock touched $17.54 price level, adding 10.65% to its value on the day. Cabaletta Bio Inc’s shares saw a change of -22.73% in year-to-date performance and have moved -7.49% in past 5-day. Cabaletta Bio Inc (NASDAQ:CABA) showed a performance of -20.45% in past 30-days. Number of shares sold short was 7.01 million shares which calculate 8.13 days to cover the short interests.
Cabaletta Bio Inc (CABA) estimates and forecasts
Statistics highlight that Cabaletta Bio Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 9.42% of value to its shares in past 6 months, showing an annual growth rate of 12.15% while that of industry is 12.10. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 25.00% in the current quarter and calculating 2.20% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -26.58% during past 5 years.
CABA Dividends
Cabaletta Bio Inc is more likely to be releasing its next quarterly report between March 14 and March 18 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Cabaletta Bio Inc (NASDAQ:CABA)’s Major holders
Insiders are in possession of 3.53% of company’s total shares while institution are holding 114.31 percent of that, with stock having share float percentage of 118.49%. Investors also watch the number of corporate investors in a company very closely, which is 114.31% institutions for Cabaletta Bio Inc that are currently holding shares of the company. Fred Alger Management, LLC is the top institutional holder at CABA for having 4.57 million shares of worth $59.04 million. And as of Jun 29, 2023, it was holding 11.49% of the company’s outstanding shares.
The second largest institutional holder is Adage Capital Partners GP L.L.C., which was holding about 3.27 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 8.21% of outstanding shares, having a total worth of $42.17 million.
On the other hand, Alger Small Cap Focus Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jul 30, 2023, the former fund manager was holding 3.22 million shares of worth $43.87 million or 8.09% of the total outstanding shares. The later fund manager was in possession of 1.14 million shares on Jun 29, 2023, making its stake of worth around $14.75 million in the company or a holder of 2.87% of company’s stock.
